Biostax Corp (BTAX)

[ssc]

I guess you didn't understand my point. You are assuming the curent cbli share price stays the same AFTER the 26 million additional shares are issued for cyto. I am saying the current cbli market cap will be the newly merged company's market cap; that the market is already pricing in the merger. What made cbli go from $2 to $6? The merger. So I am saying it is already priced in.

So take the current $90 million cbli market cap, issue an sdditional 26 million shares to cyto shareholders and you have about 40 million o/s. Divide $90 million by 40 million shares and you get $2.25/share. This gives a price of less than 2 cents for imun.

It's ok if you disagree with my calculations, but they are not wrong. The difference here is that you are using a value for cyto based on whatever assumptions you choose to use, while I am basing my calculations on what the market is saying right now based on the actual cbli and imun share prices.

The real question is what will happen when the outstanding shares goes from 15 million to 40 million. The answer will be known after the merger goes through.